Snake (Bothrops lanceolatus) F(ab')2 antivenom (equine) use in Martinique: Safety and efficacy;Tolerance et efficacite d'un fragment F(ab')2 antivenimeux (equin) specifique administre par voie intraveineuse dans le traitement des morsures de serpent (Bothrops lanceolatus) en Martinique

Reanimation Urgences

Volumn 7, Issue 4, 1998, Pages 381-387

  Thomas, L ^a   Tyburn, B ^b   Lang, J ^c   Ketterle J ^a   Biao, T ^a   Moravie, V ^a   Rouvel, C ^a   Numeric, P ^a  

^a CHRU   (Martinique)

^b CHG   (Martinique)

^c Pasteur Mérieux Connaught   (France)

Author keywords

Antivenins; Bothrops; Clinical trial; Martinique; Snake bites

Indexed keywords

ADRENALIN; BOTHROFAV; GAMMATETANOS; METHYLPREDNISOLONE; NADROPARIN; PARACETAMOL; PENICILLIN G; SNAKE VENOM ANTISERUM; TETANUS ANTIBODY; TETANUS TOXOID; UNCLASSIFIED DRUG;

ARTICLE; BRONCHOSPASM; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ENVENOMATION; HUMAN; HYPOTENSION; IMMUNOTHERAPY; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; SERUM SICKNESS; SNAKEBITE; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0344791674     PISSN: 11646756     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1164-6756(98)80004-2     Document Type: Article

References (14)

1. 1 Thomas L, Tyburn B, Ketterle J, Rieux D, Garnier D, Smadja D et al. Troubles de la coagulation et thromboses induites par la morsure de serpent (Bothrops lanceolatus) chez l'homme en Martinique. Réan Urg 1994 ; 3 : 25-30
2. 2 Thomas L, Tyburn B, Bucher B, Pecout F, Ketterlé J, Rieux D et al. Prevention of thromboses in human patients with Bothrops lanceolatus envenoming in Martinique: failure of anticoagulants and efficacy of a monospecific antivenom. Am J Trop Med Hyg 1995 ; 52 : 419-26
3. 3 Chippaux JP, Goyffon M. La sérothérapie antivenimeuse : ses applications, ses limites, son avenir. Bull Soc Pathol Exot 1991 ; 84 : 286-97
4. 2 antivenoms. An example: new polyvalent European viper antivenom (equine). In: Bon C, Goyffon M, eds. Envenomings and their Treatments. Lyon: Fondation Marcel Mérieux; 1996. p 161-72
5. 5 Reid HA, Theakston RDG. The management of snake bite. Bull WHO 1983 ; 61 : 885-95
6. 6 Sutherland SK. Antivenom use in Australia. Premedication, adverse reactions and use of venom detection kits. Med J Aust 1992 ; 157 : 734-9
7. 7 Jurkovich GJ, Luterman A, McCullar K, Ramenofsky ML, Curreri PW. Complications of Crotalidae antivenin therapy. J Trauma 1988 ; 28 : 1032-7
8. 8 Cardoso JLC, Fan HW, França FOS, Jorge MT, Leite RP, Nishioka SA et al. Randomized comparative trial of three antivenoms in the treatment of envenoming by lance-headed vipers (Bothrops jararaca) in São Paulo, Brazil. Q J Med 1993 ; 86 : 315-25
9. 9 Karlson-Stiber C, Persson H. Antivenom treatment in Vipera berus envenoming. Report of 30 cases. J Int Med 1994 ; 235 : 57-61
10. 10 DeSilva A, Mendis S, Warrell DA. Neurotoxic envenoming by the Sri Lankan krait (Bungarus ceylonicus) complicated by traditional treatment and a reaction to antivenom. Trans R Soc Trop Med Hyg 1993 ; 87 : 682-4
11. 11 Jorge MT, Cardiso JLC, Castro SCB, Ribeiro L, Franca FOS, Sbrogio De Almeida ME et al. A randomized "blinded" comparison of two doses of antivenom in the treatment of Bothrops envenoming in São Paulo, Brazil. Trans R Soc Trop Med Hyg 1995 ; 89 : 111-4
12. 12 Caiaffa WT, Vlahov D, Antunes CM, De Oliveira HR, Diniz CR. Snake bite and antivenom complications in Belo Horizonte, Brazil. Trans R Soc Trop Med Hyg 1994 ; 88 : 81-5
13. 13 Bush SP, Jansen PW. Severe rattlesnake envenomation with anaphylaxis and rhabdomyolysis. Ann Emerg Med 1995 ; 25 : 845-8
14. 14 Bucher B, Canonge D, Thomas L, Tyburn B, Robbe-Vincent A, Choumet V et al. Clinical indicators of envenoming and serum levels of venom antigens in patients bitten by Bothrops lanceolatus in Martinique. Trans R Soc Trop Med Hyg 1997 ; 91 : 186-90